Testing stimulation in people with an implanted retinal prosthesis
Part of Eyes & vision, Genetic & congenital clinical trials.
This study looks at how retinal stimulation works for people who already have an Argus II retinal prosthesis implanted. It may help researchers understand how well the stimulation creates a visual perception and how reliably people can do the required testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an Argus II retinal prosthesis surgically implanted
- Your device has at least 5 working electrodes that create a sensation when stimulated
- You can follow the study schedule and testing instructions
- You are not enrolled in another research drug or device study at the same time
- You can understand the study and communicate your consent and needs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, DSP-3077, given as a single injection into one eye to see if it is safe for people with retinitis pigmentosa. It is for adults with advanced vision loss who have no other major eye diseases.
This study tests a non-invasive (no surgery) ultrasound stimulation approach to see if it can help restore vision in people with age-related macular degeneration (AMD) or retinitis pigmentosa (RP). It focuses on whether the treatment can be safely given and whether vision-related changes can be measured.
This study will check if certain vision tests work well in people with retinal diseases like retinitis pigmentosa or Stargardt. Results will help design future trials.
This Phase 1/2 study tests a gene therapy treatment (BS01) in people with retinitis pigmentosa to try to improve or preserve vision. You may be a candidate if your vision in at least one eye is quite limited and you haven’t had certain gene therapies before.
This trial tests whether tiny particles from stem cells, called extracellular vesicles, can help people with retinitis pigmentosa. It aims to see if these particles are safe and can improve vision.
This pilot study tests an implant called AuTNA I in adults with retinitis pigmentosa who currently have no or only very limited light perception. The goal is to see whether the implant can work safely and potentially improve vision in a carefully selected group of people.
Hear when a new Retinitis Pigmentosa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.